A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

NCT04100018 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1030

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: Nivolumab
DRUG: Prednisone
DRUG: Docetaxel
OTHER: Placebo

Sponsor

Bristol-Myers Squibb